IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Juniper Pharmaceuticals Inc

CUSIP: 48203L907 | 3 institutional holders

Quarters

Q2 2018Q1 2018Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile